DMO
Western Asset Mortgage Opportunity Fund Inc.
$11.13
+0.72%
No data for this timeframe.
Vol
Inst. Holders3 funds
Inst. Value$2.1M
Inst. Activity0 buys / 1 sells
Insider Activity0B / 1S
Insider Net $-$15.5K
Recent Activity
Apr 13, 2026
Insider
COLMAN CAROL L sold 1,400 shares
Director @ $11.07 ($15.5K)
Inst.
WELLS FARGO & COMPANY/MN — NEAR_EXIT
2 shares ($18.00)
Inst.
WELLS FARGO & COMPANY/MN — NEAR_EXIT
91 shares ($1.1K)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $1.9M | TRIM |
| BANK OF AMERICA CORP | $188.4K | — |
| WELLS FARGO & COMPANY/MN | $18.00 | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 13, 2026 | COLMAN CAROL | SELL | $15.5K |
3 institutional holders with $2.1M total value (186,960 shares) as of 2025-Q4. Top holders: MORGAN, BANK, WELLS. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 169,919 | $1.9M | 90.9% | TRIM -40.8% |
| 2 | BANK OF AMERICA CORP /DE/ | 17,039 | $188.4K | 9.1% | — |
| 3 | WELLS FARGO & COMPANY/MN | 2 | $18.00 | 0.0% | NEAR_EXIT -77.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 9 | 2 | -77.8% | $18.00 | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 2,878 | 91 | -96.8% | $1.1K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 293,730 | 173,951 | -40.8% | $2.1M | 2024-Q3 |
1 unique insiders with 1 transactions. Net insider value: -$15.5K ($0.00 bought, $15.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | COLMAN CAROL L | Director | SELL | 1,400 | $11.07 | $15.5K |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.